Ambrx Biopharma Inc.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (A…
Biotechnology
US, La Jolla [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra |
---|
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: